Search

everythinglearnresearchcommunity

for

Search:↓

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

ZDHHC13 is important for normal liver function and metabolism, affecting mitochondrial activity.

Tattooing helps treat skin conditions, reconstruct nipple-areola, mark radiation fields, and locate lesions.

Mutations in the LSS gene cause a rare type of hereditary hair loss.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Wounds on the face usually heal with scars, but understanding how some wounds heal without scars could lead to better treatments.

Spironolactone helps reduce pain and lesions in hidradenitis suppurativa patients, and lower doses are also effective.

Nude mice with grafted human skin developed scars similar to human hypertrophic scars.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Adrenal disorders can cause lasting brain and behavior issues in children.

Skin diseases significantly lower the quality of life for patients in southern Brazil, especially for younger, single, and lower-income individuals.